Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants.

Autor:	Lange NW; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Salerno DM; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Jennings DL; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Choe J; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Hedvat J; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Kovac DB; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Scheffert J; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Shertel T; Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA., Ratner LE; Department of Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA., Brown RS Jr; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Pereira MR; Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Jazyk:	angličtina
Zdroj:	American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2022 Jul; Vol. 22 (7), pp. 1925-1926. Date of Electronic Publication: 2022 Jan 19.
DOI:	10.1111/ajt.16955
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text